Calibrate Stock
Calibrate is a digital metabolic health business that is changing the way the world treats weight.
Sign up today and learn more about Calibrate Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Calibrate Stock
Calibrate is a digital metabolic health business that provides a virtual program for weight loss. It is creating a new category by improving metabolic health to drive long-term, sustainable weight loss with a program designed by world leaders in obesity and nutrition science. Calibrate combines FDA-approved metabolic medication with a holistic curriculum and 1:1 virtual coaching sessions that drive lasting behavior change. The company was founded in 2020 and is headquartered in New York.
Funding History
| January 2021 | $2.1M |
|---|---|
| January 2021 | $3.0M |
| January 2021 | $15.1M |
| July 2021 | $76.1M |
Management
Founder, CEO
Isabelle Kenyon
Chief Medical Officer
Kim Boyd
Chief Marketing Officer
Katy Marshall
COO
Claudia Huapaya
Board Member
Brian Singerman
Medical Director
Sona Shah
Director, Business Operations
Sintha Rajasingham
Board Member
Emily Melton
Board Member
Kira Wampler
Press
fiercehealthcare - Feb, 18 2024
Metabolic health startup Calibrate names new CEO as it eyes expansion in employer, payer marketendpts - Nov, 2 2023
Weight loss startup Calibrate raises $29M as part of private equity restructuringfortune - Oct, 31 2023
Exclusive: CEO of Ozempic prescription startup Calibrate steps down as investors eye ârapid down-sizingâ of consumer businessmedcitynews - Oct, 24 2023
Weight Loss Startup Calibrate Is Changing Handsbusinessinsider - Oct, 20 2023
Exclusive: Weight-loss startup Calibrate is selling itself to a private equity firm as patient complaints mountEquityZen Recognized As:
